{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:44:43Z","timestamp":1761518683989,"version":"3.30.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1053\/jarr.2001.21703","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"64-69","source":"Crossref","is-referenced-by-count":21,"title":["Post-Transplant Diabetes: Incidence, Relationship to Choice of Immunosuppressive Drugs, and Treatment Protocol"],"prefix":"10.1053","volume":"8","author":[{"given":"Mariana S.","family":"Markell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jarr.2001.21703_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9343(72)90126-X","article-title":"Reduction of toxicity of corticosteroid therapy after renal transplantation","volume":"53","author":"Siegel","year":"1972","journal-title":"Am J Med."},{"key":"10.1053\/jarr.2001.21703_bib2","first-page":"135","article-title":"Steroid diabetes-A sign of overtreatment with steroids in the renal allograft recipient?","volume":"54","author":"Gunnarsson","year":"1980","journal-title":"Scand J Urol Nephrol"},{"key":"10.1053\/jarr.2001.21703_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199404150-00001","article-title":"Trends in the use of glucocorticoids in renal transplantation","volume":"57","author":"Hricik","year":"1994","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(99)70101-0","article-title":"Risk for post-transplant diabetes mellitus with current immunosuppressive medications","volume":"34","author":"Weir","year":"1999","journal-title":"Am J Kidney. Dis"},{"key":"10.1053\/jarr.2001.21703_bib5","first-page":"1289","article-title":"Post-transplant diabetes mellitus-A review","volume":"58","author":"Jindal","year":"1994","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0272-6386(88)80065-9","article-title":"Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients","volume":"12","author":"Yoshimura","year":"1988","journal-title":"Am J Kidney Dis."},{"key":"10.1053\/jarr.2001.21703_bib7","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1681\/ASN.V461300","article-title":"A meta-analysis of controlled trials","volume":"4","author":"Hricik","year":"1993","journal-title":"J Am Soc Nephrol."},{"key":"10.1053\/jarr.2001.21703_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00007890-199102000-00020","article-title":"Effects of steroid withdrawal on post-transplant diabetes mellitus in cyclosporine-treated renal transplant recipients","volume":"51","author":"Hricik","year":"1991","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198709000-00010","article-title":"The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients","volume":"44","author":"Boudreux","year":"1987","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib10","first-page":"1039","article-title":"Post-renal transplant diabetes mellitus-A retrospective study","volume":"7","author":"Rao","year":"1992","journal-title":"Nephrol Dialysis Transplant."},{"key":"10.1053\/jarr.2001.21703_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-199102000-00014","article-title":"Diabetes mellitus after renal transplantation in the cyclosporine era-an analysis of risk factors","volume":"51","author":"Sumrani","year":"1991","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0272-6386(88)80065-9","article-title":"Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients","volume":"12","author":"Yoshimura","year":"1988","journal-title":"Am J Kidney Dis."},{"key":"10.1053\/jarr.2001.21703_bib13","first-page":"163","article-title":"Effects of cyclosporine on glucose metabolism","volume":"106","author":"Dresner","year":"1989","journal-title":"Surgery."},{"key":"10.1053\/jarr.2001.21703_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00007890-198809000-00007","article-title":"Impaired glucose tolerance in cyclosporine treated renal graft recipients","volume":"46","author":"Ost","year":"1988","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib15","first-page":"4015","article-title":"Cyclosporine A in low doses induces functional and morphologic changes in rat pancreatic B cells","volume":"19","author":"Fehmann","year":"1987","journal-title":"Transplant Proc."},{"key":"10.1053\/jarr.2001.21703_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00007890-198806000-00006","article-title":"Cyclosporine's effect on canine pancreatic endocrine function","volume":"45","author":"Garvin","year":"1988","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-199109000-00022","article-title":"Cyclosporine's effect on insulin secretion in patients with kidney transplants","volume":"52","author":"Esmatjes","year":"1991","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib18","first-page":"278","article-title":"Posttransplant hyperglycemia","volume":"47","author":"Roth","year":"1989","journal-title":"Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib19","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/00007890-199206000-00004","article-title":"Recovery and hypersecretion of insulin and reversal of insulin resistance on withdrawal of short-term cyclosporine treatment","volume":"53","author":"Wahlstrom","year":"1992","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/diab.36.8.952","article-title":"Role of cyclosporine A in macro-molecular synthesis of beta-cells","volume":"36","author":"Eun","year":"1987","journal-title":"Diabetes."},{"key":"10.1053\/jarr.2001.21703_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00275649","article-title":"Long-term effects of cyclosporine A on cultured mouse pancreatic islets","volume":"17","author":"Andersson","year":"1984","journal-title":"Diabetologia."},{"key":"10.1053\/jarr.2001.21703_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/diab.35.9.1049","article-title":"Direct effects of cyclosporine A on human pancreatic betacells","volume":"35","author":"Neilson","year":"1986","journal-title":"Diabetes."},{"key":"10.1053\/jarr.2001.21703_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/diab.38.4.465","article-title":"Synthesis-secretion coupling of insulin: Effects of cyclosporine","volume":"38","author":"Gillison","year":"1989","journal-title":"Diabetes"},{"key":"10.1053\/jarr.2001.21703_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/00007890-199111000-00026","article-title":"Inhibition by cyclosporine of insulin secretion-A beta cell specific alteration of islet tissue function","volume":"52","author":"Gillison","year":"1991","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-2007-978954","article-title":"Mechanism of the diabetogenic action of cyclosporine A","volume":"30","author":"Menegazzo","year":"1998","journal-title":"Horm Metab Res."},{"key":"10.1053\/jarr.2001.21703_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1399-0012.1989.tb00551.x","article-title":"Cyclosporineinduced diabetes mellitus in renal transplants","volume":"3","author":"Mejia","year":"1989","journal-title":"Clin Transplant."},{"key":"10.1053\/jarr.2001.21703_bib27","first-page":"278","article-title":"Posttransplant hyperglycemia","volume":"47","author":"Roth","year":"1989","journal-title":"Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/00007890-199606150-00005","article-title":"One-year follow-up of an open label trial of FK506 for primary kidney transplantation: A report of the US Multicenter FK506 Kidney Transplant Group","volume":"61","author":"Vincenti","year":"1996","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000658-199009000-00008","article-title":"Liver, kidney, and thoracic organ transplantation under FK506","volume":"212","author":"Todo","year":"1990","journal-title":"Ann Surg."},{"key":"10.1053\/jarr.2001.21703_bib31","first-page":"3169","article-title":"New onset of diabetes mellitus in FK506 vs cyclosporine-treated kidney transplant recipients","volume":"23","author":"Scantlebury","year":"1991","journal-title":"Transplant Proc."},{"key":"10.1053\/jarr.2001.21703_bib32","first-page":"814","article-title":"FK506 in clinical kidney transplantation","volume":"27","author":"Shapiro","year":"1995","journal-title":"Transplant Proc."},{"key":"10.1053\/jarr.2001.21703_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00002480-199903000-00223","article-title":"Analysis of risk factors in tacrolimus-associated post-transplant diabetes (PTDM)","volume":"45","author":"Markell","year":"1999","journal-title":"ASAIO J."},{"key":"10.1053\/jarr.2001.21703_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/ndt\/15.6.867","article-title":"Tacrolimus reversibly reduces insulin secretion in pediatric renal transplant recipients","volume":"15","author":"Filler","year":"2000","journal-title":"Nephrol Dialysis Transplant."},{"key":"10.1053\/jarr.2001.21703_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00007890-199204000-00033","article-title":"Morphological and functional changes of islets of Langerhans in FK506-treated rats","volume":"53","author":"Hirano","year":"1992","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib36","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/00007890-199506000-00018","article-title":"Transcriptional inhibition of insulin by FK506 and possible involvement of FK-binding protein 12 in pancreatic beta-cell","volume":"59","author":"Tamura","year":"1995","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib37","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1172\/JCI119105","article-title":"Effects of tacrolimus (FK506) on human insulin gene expression insulin mRNA levels, and insulin secretion in HITT15 cells","volume":"98","author":"Redmon","year":"1996","journal-title":"J Clin Invest."},{"key":"10.1053\/jarr.2001.21703_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0026-0495(92)90192-D","article-title":"Effect of Fk506 on insulin secretion in normal dogs","volume":"41","author":"Strasser","year":"1992","journal-title":"Metabolism."},{"key":"10.1053\/jarr.2001.21703_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00007890-199507000-00007","article-title":"The effect of FK506 on glycemic response as assessed by hyperglycemic clamp technique","volume":"60","author":"Strumph","year":"1995","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1464-5491.2000.00206.x","article-title":"Predicting the occurrance of diabetes mellitus in heart transplant recipients","volume":"17","author":"Depczynski","year":"2000","journal-title":"Diabet Med."},{"key":"10.1053\/jarr.2001.21703_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-8227(98)00098-9","article-title":"Post-transplant diabetes with anti-glutamic acid decarboxylase antibody during tacrolimus therapy","volume":"42","author":"Yoshioka","year":"1998","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1053\/jarr.2001.21703_bib42","first-page":"S4","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"23","author":"Gavin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1053\/jarr.2001.21703_bib43","first-page":"2136","article-title":"Interaction between glipizide and cyclosporine","volume":"25","author":"Chidester","year":"1993","journal-title":"Transplant Proc."},{"key":"10.1053\/jarr.2001.21703_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1399-0012.1998.tb01013.x","article-title":"Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients","volume":"12","author":"Sagedal","year":"1998","journal-title":"Clin Transplant."},{"key":"10.1053\/jarr.2001.21703_bib45","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/00007890-199805270-00021","article-title":"Potential interaction of troglitazone and cyclosporine","volume":"65","author":"Kaplan","year":"1998","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-199807270-00024","article-title":"Effect of troglitazone on cyclosporine whole blood levels","volume":"66","author":"Burgess","year":"1998","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1520-670X(1999)12:4<375::AID-JTRA11>3.0.CO;2-R","article-title":"Control of steroid-induced diabetes with supplemental chromium","volume":"12","author":"Ravina","year":"1999","journal-title":"J Trace Elem Exp Med."},{"key":"10.1053\/jarr.2001.21703_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1464-5491.1999.00004.x","article-title":"Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium","volume":"16","author":"Ravina","year":"1999","journal-title":"Diabet Med."},{"key":"10.1053\/jarr.2001.21703_bib49","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00007890-199802150-00014","article-title":"Diabetes mellitus after renal transplantation: As deleterious as non-transplant associated diabetes?","volume":"65","author":"Miles","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/jarr.2001.21703_bib50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1399-0012.1994.tb00262.x","article-title":"Outcome statistics of renal transplants with an emphasis on long-term survival","volume":"8","author":"Cecka","year":"1994","journal-title":"Clin Transplant."},{"key":"10.1053\/jarr.2001.21703_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"Ojo","year":"2000","journal-title":"Kidney Int."},{"key":"10.1053\/jarr.2001.21703_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy for human renal transplantation","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation."},{"key":"10.1053\/jarr.2001.21703_bib53","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00007890-199311000-00017","article-title":"The efficacy and toxicity of rapamycin in murine islet transplantation","volume":"56","author":"Fabian","year":"1993","journal-title":"Transplantation."}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444901700064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444901700064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T19:03:57Z","timestamp":1733598237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444901700064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S1073444901700064"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2001.21703","relation":{},"ISSN":["1073-4449"],"issn-type":[{"type":"print","value":"1073-4449"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}